Antituberculosis Drugs
This volume deals specifically with those antituberculosis drugs which passed the preclinical phase and have been or are used in the treatment of tuberculosis and other mycobacterial diseases (except leprosy) in at least some parts of the world. Despite this restriction, there are 14 such drugs, and as a result this volume has reached rather large proportions. To prevent it from becoming even larger and more unwidely, most derivatives of antituberculotics have been omitted, especially where it is claimed that they provide only better bioavailibility or tolerability. Only in the chapter on the chemotherapy of diseases due to so-called atypical…
Mehr
CHF 179.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V103:
Folgt in ca. 5 Arbeitstagen
Produktdetails
- ISBN: 978-3-642-72875-4
- EAN: 9783642728754
- Produktnummer: 15420969
- Verlag: Springer Berlin Heidelberg
- Sprache: Englisch
- Erscheinungsjahr: 2011
- Seitenangabe: 596 S.
- Masse: H24.4 cm x B17.0 cm x D3.1 cm 1'014 g
- Auflage: Softcover reprint of the original 1st ed. 1988
- Abbildungen: Paperback
- Gewicht: 1014
1 weiteres Werk von Karl (Hrsg.) Bartmann:
Bewertungen
Anmelden